1 Min Read
Oct 11 (Reuters) - Vivus Inc said it would market its erectile dysfunction drug, Stendra, in the United States and Canada with Auxilium Pharmaceuticals Inc.
Auxilium said the deal, worth up to $300 million, would add to its earnings in 2015.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.